Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Engel

Showing results (41-50 of 142) with videos related to

Pageof 15
Sort By:
Biochemical Society Transactions|July 28, 2010
Tau phosphorylation in hippocampus results in toxic gain-of-functionJesús Avila, Elena Gómez de Barreda, Tobias Engel, et al.
Lung Cancer (Amsterdam, Netherlands)|March 8, 2011
Efficacy of bevacizumab (Bev) plus chemotherapy (CT) compared to CT alone in previously untreated locally advanced or metastatic non-small cell lung cancer (NSCLC): systematic review and meta-analysisTobias Engel Ayer Botrel, Otávio Clark, Luciana Clark, et al.
Purinergic Signalling|February 15, 2023
Differently expression of the metabotropic P2Y receptor family after hypoxia-induced seizures in neonates and seizure suppression via P2Y<sub>1</sub> receptor agonismJonathon Smith, Beatriz Gil Lopez-Avila, Tobias Engel, et al.
BMC Cancer|August 26, 2016
Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysisTobias Engel Ayer Botrel, Luciana Gontijo de Oliveira Clark, Luciano Paladini, et al.
International Journal of Molecular Sciences|August 7, 2021
Progressive Mitochondrial SOD1<sup>G93A</sup> Accumulation Causes Severe Structural, Metabolic and Functional Aberrations through OPA1 Down-Regulation in a Mouse Model of Amyotrophic Lateral SclerosisIago Méndez-López, Francisco J Sancho-Bielsa, Tobias Engel, et al.
Neurobiology of Aging|August 2, 2005
Cooexpression of FTDP-17 tau and GSK-3beta in transgenic mice induce tau polymerization and neurodegenerationTobias Engel, José J Lucas, Pilar Gómez-Ramos, et al.
International Journal of Physiology, Pathophysiology and Pharmacology|January 16, 2013
P2X7 receptor in epilepsy; role in pathophysiology and potential targeting for seizure controlTobias Engel, Alba Jimenez-Pacheco, Maria Teresa Miras-Portugal, et al.
International Journal of Molecular Sciences|July 13, 2024
The Purinergic P2X7 Receptor as a Target for Adjunctive Treatment for Drug-Refractory EpilepsyDivyeshz Thakku Sivakumar, Krishi Jain, Noura Alfehaid, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 25, 2010
Efficacy of palonosetron (PAL) compared to other serotonin inhibitors (5-HT3R) in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately or highly emetogenic (MoHE) treatment: systematic review and meta-analysisTobias Engel Ayer Botrel, Otávio Augusto C Clark, Luciana Clark, et al.
Brain Research|August 28, 2012
Bi-lateral changes to hippocampal cholesterol levels during epileptogenesis and in chronic epilepsy following focal-onset status epilepticus in miceMaura Heverin, Tobias Engel, Steve Meaney, et al.
Pageof 15

Showing results (41-50 of 142) with videos related to

Sort By:
Pageof 15
Biochemical Society Transactions|July 28, 2010
Tau phosphorylation in hippocampus results in toxic gain-of-functionJesús Avila, Elena Gómez de Barreda, Tobias Engel, et al.
Lung Cancer (Amsterdam, Netherlands)|March 8, 2011
Efficacy of bevacizumab (Bev) plus chemotherapy (CT) compared to CT alone in previously untreated locally advanced or metastatic non-small cell lung cancer (NSCLC): systematic review and meta-analysisTobias Engel Ayer Botrel, Otávio Clark, Luciana Clark, et al.
Purinergic Signalling|February 15, 2023
Differently expression of the metabotropic P2Y receptor family after hypoxia-induced seizures in neonates and seizure suppression via P2Y<sub>1</sub> receptor agonismJonathon Smith, Beatriz Gil Lopez-Avila, Tobias Engel, et al.
BMC Cancer|August 26, 2016
Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysisTobias Engel Ayer Botrel, Luciana Gontijo de Oliveira Clark, Luciano Paladini, et al.
International Journal of Molecular Sciences|August 7, 2021
Progressive Mitochondrial SOD1<sup>G93A</sup> Accumulation Causes Severe Structural, Metabolic and Functional Aberrations through OPA1 Down-Regulation in a Mouse Model of Amyotrophic Lateral SclerosisIago Méndez-López, Francisco J Sancho-Bielsa, Tobias Engel, et al.
Neurobiology of Aging|August 2, 2005
Cooexpression of FTDP-17 tau and GSK-3beta in transgenic mice induce tau polymerization and neurodegenerationTobias Engel, José J Lucas, Pilar Gómez-Ramos, et al.
International Journal of Physiology, Pathophysiology and Pharmacology|January 16, 2013
P2X7 receptor in epilepsy; role in pathophysiology and potential targeting for seizure controlTobias Engel, Alba Jimenez-Pacheco, Maria Teresa Miras-Portugal, et al.
International Journal of Molecular Sciences|July 13, 2024
The Purinergic P2X7 Receptor as a Target for Adjunctive Treatment for Drug-Refractory EpilepsyDivyeshz Thakku Sivakumar, Krishi Jain, Noura Alfehaid, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 25, 2010
Efficacy of palonosetron (PAL) compared to other serotonin inhibitors (5-HT3R) in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately or highly emetogenic (MoHE) treatment: systematic review and meta-analysisTobias Engel Ayer Botrel, Otávio Augusto C Clark, Luciana Clark, et al.
Brain Research|August 28, 2012
Bi-lateral changes to hippocampal cholesterol levels during epileptogenesis and in chronic epilepsy following focal-onset status epilepticus in miceMaura Heverin, Tobias Engel, Steve Meaney, et al.
Pageof 15